CA2926348A1 - Methode efficace de preparation de citrate de tofacitinib - Google Patents

Methode efficace de preparation de citrate de tofacitinib Download PDF

Info

Publication number
CA2926348A1
CA2926348A1 CA2926348A CA2926348A CA2926348A1 CA 2926348 A1 CA2926348 A1 CA 2926348A1 CA 2926348 A CA2926348 A CA 2926348A CA 2926348 A CA2926348 A CA 2926348A CA 2926348 A1 CA2926348 A1 CA 2926348A1
Authority
CA
Canada
Prior art keywords
give
methyl
pyrrolo
methylpiperidin
pyrimidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2926348A
Other languages
English (en)
Inventor
Jacopo BONANOMI
Stella DEFIORE
Barbara NOVO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olon SpA
Original Assignee
Olon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olon SpA filed Critical Olon SpA
Publication of CA2926348A1 publication Critical patent/CA2926348A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2926348A 2015-04-10 2016-04-07 Methode efficace de preparation de citrate de tofacitinib Abandoned CA2926348A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102015000011506 2015-04-10
IT015000011506 2015-04-10

Publications (1)

Publication Number Publication Date
CA2926348A1 true CA2926348A1 (fr) 2016-10-10

Family

ID=57122289

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2926348A Abandoned CA2926348A1 (fr) 2015-04-10 2016-04-07 Methode efficace de preparation de citrate de tofacitinib

Country Status (1)

Country Link
CA (1) CA2926348A1 (fr)

Similar Documents

Publication Publication Date Title
US9828380B2 (en) Efficient method for the preparation of tofacitinib citrate
JP5587213B2 (ja) モルホリン誘導体の調製
KR20150053816A (ko) 테노포비어 디소프록실의 결정형 및 그의 제조방법
US9834561B2 (en) Process for preparing ibrutinib and its intermediates
JP5696035B2 (ja) アルガトロバン一水和物の多形体及びその合成方法
JP5097770B2 (ja) ドルゾラミドの調製方法
WO2015011609A1 (fr) Procédé de préparation de linagliptine et d'un intermédiaire de celle-ci
US9771364B2 (en) Process for preparation of (2S,5R)-6-sulphooxy-7-oxo-2-[((3R)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane
RU2320655C2 (ru) УЛУЧШЕННЫЙ СПОСОБ ПОЛУЧЕНИЯ α-ПОЛИМОРФНОГО БРОМГИДРАТА ЭЛЕТРИПТАНА
CA2926348A1 (fr) Methode efficace de preparation de citrate de tofacitinib
EP1564209A1 (fr) Procédé pour la préparation de l'acide 13-cis-rétinoique
JP7379381B2 (ja) リナグリプチンおよびその塩の製造のための中間体およびプロセス
WO2020213714A1 (fr) Procédé de production de cis-(-)-fluocino-pipéridol
US20070004737A1 (en) Process of purifying tadalafil
JP2003119197A (ja) ２−アミノ−６−シクロプロピルアミノ−９ｈ−プリンの製造法
CN122003413A (zh) Jak抑制剂的结晶多晶型物形式a和其制备方法
AU2024243114A1 (en) Process for the production of (1r,2s,5r)-1-amino-5-[2-(dihydroxyboranyl)ethyl]-2-[(dimethylamino)methyl]cyclohexane-1-carboxylic acid
EP3031800B1 (fr) Procédé pour la préparation de miglustat de haute pureté
KR100856891B1 (ko) 수마트립탄의 제조방법
JP2008505860A (ja) ２，３−ジアミノプロピオン酸誘導体のエナンチオマー体の製造方法。
WO2010079605A1 (fr) Procédé de production de la 1-benzyl-3-aminopyrrolidine de pureté élevée
JP2018525366A (ja) イブルチニブの製法及び新規な合成中間体
KR20060125218A (ko) 광학활성 벤족사진 유도체의 제조방법
CA2688018A1 (fr) Procede de preparation de derives du chromane
MXPA01004227A (es) Procedimiento para la preparacion de 4-((2'-5'-diamino-6'-halopirimidin- 4'-il)amino)- ciclopent-2- enilmetanoles

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20200831